INMED PHARMACEUTICALS INC. Inventory, Raw Materials, Net of Reserves
INMED PHARMACEUTICALS INC. (INM) had Inventory, Raw Materials, Net of Reserves of $1.14 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Notes › Inventory
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2022-05-13
- 2022-03-31: Inventory, Raw Materials, Net of Reserves $1.14M.
- 2021-12-31: Inventory, Raw Materials, Net of Reserves $826.68K.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2022-03-31 | $1.14M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $826.68K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |